Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Proposed HHS budget would close NINR, cut nursing programs
The American Nurses Association is warning that eliminating support for the training and research offered by the National Institute of Nursing Research could be devastating to the public, as many programs support specialties such as maternal and mental health.
Family of heart patient who died awarded $45M after suing health system for negligence
The 55-year-old patient woke up experiencing chest pain one morning and an ambulance was called. He was dead just a few hours later. His family's lawsuit argued that delays in care, communication errors and other issues were directly responsible for his death.
Leaked HHS budget reveals 30% cuts, elimination of many core services
A proposal for the massive restructuring of the Department of Health and Human Services ends funding to programs associated with chronic disease management, lead safety, and Head Start. However, HHS is adding a new department to focus on understanding the cause of long-term illness.
RadNet leaders discuss rationale behind blockbuster $103M iCAD AI acquisition
RadNet provides 1.9M mammograms per year in the U.S., and adding iCAD’s installed customer base would boost the number of impacted exams to 10M.
Interventional radiologists ‘markedly’ increase billing for nonprocedural work, despite drop in overall doc count
"These findings underscore IR’s accelerating transition toward comprehensive patient care, with significant implications for training, practice management, and the specialty’s role within the broader healthcare landscape," experts write.

GE HealthCare to acquire AI business from ultrasound firm for $51M, plus more vendor news

Also, Hologic expected to generate $800M in free cash flow, full-body MRI startup raises $27M, and the FDA clears solutions from Hyperfine, Subtle Medical and Positrigo.

Cordis has received U.S. Food and Drug Administration (FDA) approval for its new MYNX Control Venous Vascular Closure Device (VCD) for 6F-12F access sites. The company hopes to launch the newly approved extravascular closure device in the months ahead.

Cordis gains FDA approval for new closure device, inks pricing deal with Premier

The newly approved extravascular closure device was designed for procedures with access sites from 6 to 12 French. It uses the same proprietary GRIP technology found in other Cordis interventional devices.

How the proposed Medicare Physician Fee Schedule could impact nuclear cardiology

The American Society of Nuclear Cardiology explored some key points included in the 2025 Medicare Physician Fee Schedule proposed rule.

healthcare money economics dollar stethoscope acquire merger

Private equity firms back less than 4% of healthcare providers, report finds

According to an analysis from PitchBook, providers backed by private equity make up only 3.3% of the total market by revenue.

Gallup: 45% of adults cannot afford the care they need

A survey from West Health and Gallup found fewer Americans can now afford premiums, copays, prescriptions and medical bills, with numbers falling across all age demographics since 2022.

Private equity firm acquires medical imaging equipment supplier from Philips

Agito Medical was first founded in 2004 and acquired by the Amsterdam-based original equipment manufacturer in 2018.

Radiology AI firm AIRS Medical raises $20M in Series C financing

The Korean company’s flagship product, SwiftMR, is a deep learning solution that helps providers reduce scan times while maintaining image quality.

stroke brain dementia alzheimer's puzzle mental health

Lantheus acquires developer of next-generation PET imaging agent for Alzheimer’s

Meilleur Technologies’ portfolio includes the worldwide exclusive rights to NAV-4694, also known as F18-flutafuranol, which is in phase 3 trials.

Economics

Proposed HHS budget would close NINR, cut nursing programs

Family of heart patient who died awarded $45M after suing health system for negligence

Leaked HHS budget reveals 30% cuts, elimination of many core services

RadNet leaders discuss rationale behind blockbuster $103M iCAD AI acquisition

Interventional radiologists ‘markedly’ increase billing for nonprocedural work, despite drop in overall doc count